In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Vaxcyte Inc (NASDAQ: PCVX) was $30.55 for the day, up 0.99% from the previous closing price of $30.25. In other words, the price has increased by $0.99 from its previous closing price. On the day, 2.03 million shares were traded. PCVX stock price reached its highest trading level at $30.95 during the session, while it also had its lowest trading level at $29.87.
Ratios:
Our analysis of PCVX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.11 and its Current Ratio is at 11.11. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.Mizuho initiated its Buy rating on December 07, 2023, with a $69 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.
Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 3966092544 and an Enterprise Value of 2387924992.
Stock Price History:
The Beta on a monthly basis for PCVX is 1.04, which has changed by -0.6146569 over the last 52 weeks, in comparison to a change of 0.1590569 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $27.66. The 50-Day Moving Average of the stock is -8.66%, while the 200-Day Moving Average is calculated to be -47.09%.
Shares Statistics:
PCVX traded an average of 1.52M shares per day over the past three months and 1431970 shares per day over the past ten days. A total of 129.82M shares are outstanding, with a floating share count of 125.45M. Insiders hold about 3.36% of the company’s shares, while institutions hold 111.75% stake in the company. Shares short for PCVX as of 1755216000 were 11435242 with a Short Ratio of 7.55, compared to 1752537600 on 13618625. Therefore, it implies a Short% of Shares Outstanding of 11435242 and a Short% of Float of 9.86.
Earnings Estimates
A detailed examination of Vaxcyte Inc (PCVX) is currently in progress, with 5.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$1.36, with high estimates of -$1.05 and low estimates of -$1.71.
Analysts are recommending an EPS of between -$4.34 and -$5.96 for the fiscal current year, implying an average EPS of -$5.1. EPS for the following year is -$5.97, with 5.0 analysts recommending between -$4.16 and -$7.28.
